← Back to Clinical Trials
Recruiting NCT06033807

NCT06033807 Active Screening of Latent Tuberculosis Infection in School Contacts of Active Tuberculosis Patients

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06033807
Status Recruiting
Phase
Sponsor Huashan Hospital
Condition Tuberculosis
Study Type OBSERVATIONAL
Enrollment 31,440 participants
Start Date 2023-09-01
Primary Completion 2025-09-01

Eligibility & Interventions

Sex All sexes
Min Age 13 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
QuantiFERON-TB Gold (QFT) test

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 31,440 participants in total. It began in 2023-09-01 with a primary completion date of 2025-09-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this observational study is to investigate the proportion of Mycobacterium tuberculosis (MTB) infection in school contacts of active tuberculosis (ATB) patients. The main questions it aims to answer are: * the proportion of MTB infection among school contacts of ATB patients * risk factors related to tuberculosis (TB) infection * health economic evaluation of screening strategy

Eligibility Criteria

Inclusion Criteria: * 13 years old or above; * Students in junior middle school, high school and university; * Close contact of school active tuberculosis case (e.g. in the same classroom, in the same dormitory); * Himself/herself (together with his/her guardian for age under 18 years old) willing to participate in trial and sign informed consent. Exclusion Criteria: * Current clinical or sputum culture confirmed active tuberculosis * Have completed a full course of treatment for ATB or LTBI

Contact & Investigator

Central Contact

Qiaoling Ruan, PhD

✉ ruan_qiao_ling@fudan.edu.cn

📞 13661856002

Principal Investigator

Wenhong Zhang, PhD

PRINCIPAL INVESTIGATOR

Huashan Hospital

Frequently Asked Questions

Who can join the NCT06033807 clinical trial?

This trial is open to participants of all sexes, aged 13 Years or older, studying Tuberculosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06033807 currently recruiting?

Yes, NCT06033807 is actively recruiting participants. Contact the research team at ruan_qiao_ling@fudan.edu.cn for enrollment information.

Where is the NCT06033807 trial being conducted?

This trial is being conducted at Zunyi, China, Bijie, China, Bijie, China, Bijie, China and 11 additional locations.

Who is sponsoring the NCT06033807 clinical trial?

NCT06033807 is sponsored by Huashan Hospital. The principal investigator is Wenhong Zhang, PhD at Huashan Hospital. The trial plans to enroll 31,440 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology